New Itch-Relief Injection for Dogs: What Befrena Means for Las Vegas Pet Parents
Elanco began rolling out Befrena, a new itch-blocking shot for dogs, this spring. Here is what the therapy actually does, and why our valley's dry heat makes it worth a closer look this summer.
Key takeaways
- Elanco began a phased U.S. rollout of Befrena (tirnovetmab), a new injectable treatment for canine allergic itch, after the therapy earned USDA approval late last year.
- The drug works by blocking IL-31, a chemical messenger that carries itch signals to the brain, and is given as an in-clinic shot roughly every six to eight weeks.
- A national owner survey found most people wait around six weeks after their dog first starts scratching before booking a vet visit, time that can let simple itch turn into a skin infection.
- Las Vegas heat, dust and dry air can all aggravate a dog's skin, so a prompt exam still matters before starting any new itch therapy.
Figures drawn from Elanco's Befrena launch materials and its 2025 owner and veterinarian survey on canine itch.
What Befrena Actually Does
Befrena is the trade name for tirnovetmab, a lab-made antibody that Elanco Animal Health designed to target IL-31, one of the main chemical signals that tells a dog's brain to itch. By binding up that signal before it reaches the nervous system, the shot is meant to quiet chronic scratching tied to allergic and atopic skin disease rather than just numbing the skin.
It is given as an injection at the vet's office, and the labeled dosing window runs about six to eight weeks between visits. Some early-adopter clinics have reported dogs settling down within a day of the first dose, though individual results vary and every dog's skin history is different.
This is Elanco's second dermatology product to reach the market in under two years, following Zenrelia, an oral pill approved for the same itch and inflammation complaints. Having both an injectable and a pill option gives vets more room to match treatment to a dog's routine and health history.
Why Desert Living Adds to the Itch
Dry desert air pulls moisture out of a dog's skin the same way it dries out human hands and lips, which can leave already sensitive skin flakier and more reactive. Add in blowing dust, textbook Mojave allergens, and the grass and pollen that show up around irrigated Las Vegas yards and parks, and it is easy for a mild itch to snowball.
Hot pavement and shorter, faster walks during our summer heat can also mean owners spend less time closely checking paws, ears and bellies than they would on a leisurely evening stroll. That makes it easier for early skin irritation to go unnoticed until it is more advanced.
Why So Many Owners Wait Too Long
A 2025 Elanco-commissioned survey found that 89 percent of U.S. dog owners describe their dog as an 'itchy dog' who has scratched, licked or chewed at some point during the year, and 83 percent said pollen makes it noticeably worse.
Despite how common it is, owners in that same survey waited about six weeks on average after symptoms began before scheduling a vet visit, and 90 percent of veterinarians surveyed agreed that clients typically wait too long, which can let a simple hot spot turn into a deeper infection.
There is a cost angle too: the survey estimated owners spend roughly $173 more per dog during allergy season on extra shampoos, wipes and remedies they try before ever getting a proper diagnosis.
Is a New Injection Right for Your Dog?
No itch medication, new or old, is a substitute for figuring out the actual cause of the scratching. Fleas, food sensitivities, mites and secondary bacterial or yeast infections can all look like a straightforward allergy at first glance, and each needs a different treatment plan.
If your dog has been dealing with recurring itch, redness or ear trouble, the most useful first step is an in-person exam so your vet can confirm what is really going on and talk through which options, including newer ones like Befrena, might fit your dog's history and lifestyle.
Signs Your Dog's Scratching Deserves a Vet Visit
Occasional scratching is normal, but these patterns are worth mentioning to your vet sooner rather than later.
- Nonstop licking or chewing at the paws: Especially between the toes, which can signal allergies, irritation from hot pavement, or a low-grade infection.
- Red, warm patches of skin: Sometimes called hot spots, these can spread quickly and are often more uncomfortable than they look.
- Repeat ear infections: Head shaking, odor, or dark discharge that keeps coming back can point to an underlying allergy.
- Thinning fur or bald patches: Constant scratching or licking in one spot can wear the coat down over time.
- Restless nights: A dog that is up scratching instead of sleeping soundly is telling you the itch is more than minor.
- Musty or greasy-smelling skin: This can indicate a yeast or bacterial overgrowth layered on top of allergic skin.
- Flare-ups that track the seasons: Itching that gets noticeably worse with pollen, dust storms, or certain months suggests an environmental trigger.
- Rubbing or scooting on furniture or carpet: A sign your dog is trying to relieve itch or discomfort they cannot reach on their own.
Frequently Asked Questions
Is Befrena a cure for dog allergies?
No. It is designed to help control the itch signal tied to allergic skin disease, not cure the underlying allergy, and it works best alongside a full diagnosis from your veterinarian.
How is this different from other itch treatments already on the market?
It uses a lab-made antibody delivered by injection roughly every six to eight weeks, while some existing options come as a daily pill or a monthly shot, so the right choice depends on your dog and your vet's recommendation.
Can cats receive this treatment?
No, it is labeled specifically for dogs. Cats with skin or allergy issues need their own exam and a plan suited to feline skin conditions.
Does an itch injection replace flea and tick prevention?
No. Flea allergy is one of the most common itch triggers, so year-round parasite prevention still matters even if your dog starts a new itch therapy.
Sources
- Elanco Launches Befrena (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market — PR Newswire
- USDA approves drug for canine allergic and atopic dermatitis — Veterinary Practice News
- Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief — PR Newswire